{"id":"W3129416935","doi":"10.1016/j.jaad.2021.02.057","title":"Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data","year":2021,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"AbbVie","keywords":"Medicine; Discontinuation; Etanercept; Adverse effect; Psoriasis; Internal medicine; Randomized controlled trial; Certolizumab pegol; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008696651,0.0018558,0.01084319,0.001181144,0.0002354946,0.001871481,0.001473921,0.001367453,0.003274104],"category_scores_gemma":[0.01369707,0.00077402,0.01875111,0.00179734,0.0004666919,0.0009539551,0.0009006251,0.002170047,0.00028234],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009731784,"about_ca_system_score_gemma":0.0007963277,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001775156,"about_ca_topic_score_gemma":0.003494638,"domain_scores_codex":[0.9953285,0.002916776,0.0007244272,0.0005762557,0.0003120921,0.000141997],"domain_scores_gemma":[0.9903584,0.007484865,0.001187935,0.0004519415,0.0003601584,0.0001566975],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.02499038,0.00005844244,0.004073028,0.06228635,0.8837466,0.00007954503,0.00004636313,0.0009198939,0.0005164226,0.0002052577,0.0008206196,0.02225701],"study_design_scores_gemma":[0.004763129,0.0006827641,0.005676799,0.002709819,0.982866,0.00007525286,0.00003300695,0.000411344,0.0001657006,0.000598094,0.001986993,0.00003106114],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0234922,0.9731835,0.001390106,0.0002821881,0.0002695245,0.0001506018,0.0006601824,0.00004680901,0.0005248661],"genre_scores_gemma":[0.5235812,0.4680962,0.003381202,0.001357627,0.0005250865,0.0003621116,0.001771194,0.00008181642,0.000843538],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01084319,"threshold_uncertainty_score":0.04599279,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3244600785064637,"score_gpt":0.455488217822944,"score_spread":0.1310281393164802,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}